Stock ELDN ELEDON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Eledon Pharmaceuticals, Inc.

Equities

ELDN

US28617K1016

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
2.84 USD -1.73% Intraday chart for Eledon Pharmaceuticals, Inc. +18.33% +57.78%
Jun. 03 Eledon Pharmaceuticals, Inc. Presents Updated Data from Ongoing Phase 1B Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation CI
May. 13 Eledon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Noble Capital Initiates Coverage on Eledon Pharmaceuticals with Outperform Rating, $10 Price Target
MT
SVB Securities LLC Adjusts Price Target for Eledon Pharmaceuticals to $26 From $33, Reiterates Outperform Rating
MT
HC Wainwright Adjusts Eledon Pharmaceuticals' Price Target to $25 From $35, Keeps Buy Rating
MT
ELEDON PHARMACEUTICALS : SVB Leerink Adjusts Price Target on Eledon Pharmaceuticals to $33 From $34, Maintains Outperform Rating
MT
ELEDON PHARMACEUTICALS : Cantor Fitzgerald Starts Eledon Pharmaceuticals at Overweight With $25 Price Target
MT
ELEDON PHARMACEUTICALS : SVB Leerink Starts Eledon Pharmaceuticals at Outperform With $34 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELDN Stock
  4. News Eledon Pharmaceuticals, Inc.
  5. Analyst Reco.